Evaluating a Novel, Portable, Self-Administrable Device ("Beacon") That Measures Critical Flicker Frequency as a Test for Hepatic Encephalopathy.


Journal

The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 07 10 2022
accepted: 26 01 2023
pmc-release: 01 06 2024
medline: 2 6 2023
pubmed: 7 2 2023
entrez: 6 2 2023
Statut: ppublish

Résumé

We compared critical flicker frequency (CFF) thresholds obtained using a novel portable device "Beacon" with thresholds from the commercially available Lafayette Flicker Fusion System (Lafayette-FFS) in patients with cirrhosis. One hundred fifty-three participants with chronic liver disease underwent CFF testing using Beacon and Lafayette-FFS with a method-of-limits and/or forced-choice protocol. Beacon demonstrated excellent test-retest reliability (intraclass correlation 0.91-0.97) and good correlation with the Lafayette-FFS values (intraclass correlation 0.77-0.84). Forced-choice CFF were on average 4.1 Hz higher than method-of-limits descending CFFs. Beacon can be self-administered by patients with chronic liver disease and cirrhosis to measure CFF, a validated screening test for minimal hepatic encephalopathy.

Identifiants

pubmed: 36746413
doi: 10.14309/ajg.0000000000002211
pii: 00000434-202306000-00033
pmc: PMC10238616
mid: NIHMS1870994
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1096-1100

Subventions

Organisme : NIDDK NIH HHS
ID : R21 DK117431
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM012810
Pays : United States

Informations de copyright

Copyright © 2023 by The American College of Gastroenterology.

Références

Barone M, Shahini E, Iannone A, et al. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Dig Liver Dis 2018;50(5):496–500.
Kircheis G, Bode JG, Hilger N, et al. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. Eur J Gastroenterol Hepatol 2009;21(12):1383–94.
Kircheis G, Hilger N, Haussinger D. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy. Gastroenterology 2014;146(4):961–9.e11.
Torlot FJ, McPhail MJW, Taylor-Robinson SD. Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy. Aliment Pharmacol Ther 2013;37(5):527–36.
Instruments L. Flicker Fusion System, 2021 ( https://lafayetteevaluation.com/products/flicker-fusion ). Accessed September 28, 2021.
Karkar R, Kocielnik R, Zhang X, et al. Beacon: Designing a portable device for self-administering a measure of critical flicker frequency. Proc ACM Interact Mob Wearable Ubiquitous Technol. 2018;2(3):1–27.
Ampuero J, Simon M, Montoliu C, et al. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology 2015;149(6):1483–9.
Bajaj JS, Heuman DM, Wade JB, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011;140(2):478–87.e1.
Allampati S, Duarte-Rojo A, Thacker LR, et al. Diagnosis of minimal hepatic encephalopathy using stroop EncephalApp: A multicenter US-based, norm-based study. Am J Gastroenterol 2016;111(1):78–86.
Acharya C, Wade JB, Fagan A, et al. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation. Liver Transpl 2017;23(11):1396–403.
Bajaj JS. Diagnosing minimal hepatic encephalopathy: From the ivory tower to the real world. Gastroenterology 2015;149(6):1330–3.
Bajaj JS, Etemadian A, Hafeezullah M, et al. Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology 2007;45(3):833–4.
Eisen-Enosh A, Farah N, Burgansky-Eliash Z, et al. Evaluation of critical flicker-fusion frequency measurement methods for the investigation of visual temporal resolution. Sci Rep 2017;7(1):15621.
de Asis Fernandez F, Gonzalez-Mohino F, Gonzalez-Rave JM. Assessment of sensory sensitivity through critical flicker fusion frequency thresholds after a maximum voluntary apnoea. Diving Hyperb Med 2019;49(3):186–91.
Sanchez-Sanchez J, Felipe JL, Hernandez-Martin A, et al. Influence of the artificial turf certification on physical performance and muscle damage in football players (QUALTURF PROJECT). Sci Rep 2021;11(1):8625.

Auteurs

Philip Vutien (P)

University of Washington, Division of Gastroenterology and Hepatology, Seattle, Washington, USA.
Department of Medicine Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington, USA.

Richard Li (R)

Paul G. Allen School of Computer Science & Engineering, University of Washington, Seattle, Washington, USA.

Ravi Karkar (R)

Paul G. Allen School of Computer Science & Engineering, University of Washington, Seattle, Washington, USA.
Manning College of Information and Computer Sciences, University of Massachusetts Amherst, Amherst, Massachusetts, USA.

Sean A Munson (SA)

Human Centered Design & Engineering, University of Washington, Seattle, Washington, USA.

James Fogarty (J)

Paul G. Allen School of Computer Science & Engineering, University of Washington, Seattle, Washington, USA.

Kara Walter (K)

University of Washington, Division of Gastroenterology and Hepatology, Seattle, Washington, USA.

Michael Yacoub (M)

University of Washington, Division of Gastroenterology and Hepatology, Seattle, Washington, USA.

George N Ioannou (GN)

University of Washington, Division of Gastroenterology and Hepatology, Seattle, Washington, USA.
Department of Medicine Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH